sorafenib has been researched along with folic acid in 8 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (folic acid) | Trials (folic acid) | Recent Studies (post-2010) (folic acid) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 30,001 | 1,945 | 10,195 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gong, F; Ma, J; Shen, J; Zhang, F; Zhang, L; Zhang, P | 1 |
Dong, M; Kong, FM; Li, YJ; Zhou, JP | 1 |
Choi, HG; Choi, JY; Kim, JO; Poudel, BK; Thapa, RK; Yong, CS | 1 |
Cheng, Q; Gao, X; Guo, M; Jiang, P; Jiang, S; Liu, L; Liu, Q; Yao, H; Zhang, Q; Zheng, J | 1 |
Dave, V; Gupta, C; Sharma, R; Sur, S | 1 |
1 review(s) available for sorafenib and folic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for sorafenib and folic acid
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Drug Carriers; Drug Delivery Systems; Ferrocyanides; Folic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Micelles; Microscopy, Electron, Transmission; Niacinamide; Phenylurea Compounds; Sorafenib | 2013 |
Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Folic Acid; Humans; Iron; Liver Neoplasms; Magnetic Phenomena; Nanoparticles; Niacinamide; Phenylurea Compounds; Polyesters; Polyethylene Glycols; Sorafenib | 2015 |
Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Death; Drug Carriers; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Graphite; Hemolysis; Humans; Hyperthermia, Induced; KB Cells; Male; Nanomedicine; Niacinamide; Phenylurea Compounds; Phototherapy; Rats; Sorafenib; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2016 |
Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; beta-Cyclodextrins; Carcinoma, Renal Cell; Cell Cycle; Cell Movement; Cell Proliferation; Drug Synergism; Female; Folic Acid; Hepatocyte Growth Factor; Humans; Kidney Neoplasms; Kringles; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Polyethylene Glycols; Polyethyleneimine; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Folic acid modified gold nanoparticle for targeted delivery of Sorafenib tosylate towards the treatment of diabetic retinopathy.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Drug Delivery Systems; Folic Acid; Gold; Humans; Metal Nanoparticles; Sorafenib | 2020 |